Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation

Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation

Hypercholesterolemic human LDL contains oxidized subfractions that have atherogenic properties. Paradoxically, atherosclerosis incidence is low in patients with primary biliary cirrhosis (PBC), a disease characterized by marked increases in plasma LDL, including the LDL subfraction lipoprotein-X (Lp...

Full description

Bibliographic Details
Main Authors:	Po-Yuan Chang, Shao-Chun Lu, Ta-Chen Su, San-Fang Chou, Wen-Huei Huang, Joel D. Morrisett, Chu-Huang Chen, Chiau-Suong Liau, Yuan-Teh Lee
Format:	Article
Language:	English
Published:	Elsevier 2004-11-01
Series:	Journal of Lipid Research
Subjects:	hypercholesterolemia low density lipoprotein oxidation fibroblast growth factor 2 endothelium
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520341420

Similar Items

The relative atherogenicity of VLDL and LDL is dependent on the topographic site[S]
by: Eline Van Craeyveld, et al.
Published: (2010-06-01)

S-nitrosylation of ARH is required for LDL uptake by the LDL receptor
by: Zhenze Zhao, et al.
Published: (2013-06-01)

Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia
by: Vasilis Tsimihodimos, et al.
Published: (2002-02-01)

Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice[S]
by: Adam E. Mullick, et al.
Published: (2011-05-01)

Approaches to Visualising Endocytosis of LDL-Related Lipoproteins
by: Halima Siddiqui, et al.
Published: (2022-01-01)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
by: Tina Z. Khan, et al.
Published: (2021-01-01)

Improvement in Lipid Profile after Longterm Consumption of Policosanol Accompanied by Reduced Oxidation of LDL and Aortic Stiffness via CETP Inhibition in Healthy Middle-aged Women
by: Kyung-Hyun Cho, et al.
Published: (2019-01-01)

LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL[S]
by: M. John Chapman, et al.
Published: (2020-06-01)

Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene
by: Olaug K. Rødningen, et al.
Published: (1999-02-01)

Adiponectin forms a complex with atherogenic LDL and inhibits its downstream effects
by: Akemi Kakino, et al.
Published: (2021-01-01)

Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL
by: Jelena Vekic, et al.
Published: (2022-02-01)

Lipoprotein-X: A Case of Falsely Elevated LDL Hypercholesterolemia
by: Jacob Y. Mok, MD, et al.
Published: (2023-05-01)

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL
by: Kaihan Wang, et al.
Published: (2024-03-01)

In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy
by: H.C. Geiss, et al.
Published: (2004-08-01)

Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice
by: Yuko Kako, et al.
Published: (2002-06-01)

PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke[S]
by: Estelle Rousselet, et al.
Published: (2011-07-01)

Protective Role of Perivascular Adipose Tissue in Endothelial Dysfunction and Insulin-Induced Vasodilatation of Hypercholesterolemic LDL Receptor-Deficient Mice
by: Natali Baltieri, et al.
Published: (2018-03-01)

Statins and New-Onset Diabetes Mellitus: LDL Receptor May Provide a Key Link
by: Qi Yu, et al.
Published: (2017-06-01)

Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
by: Rene C. Adam, et al.
Published: (2020-09-01)

Platelet aggregation and lipoprotein levels in a patient with familial hypercholescholesterolemia after selective LDL-apheresis
by: Madalena Nunes da Silva Pares, et al.

"LDL SUBCLASS PATTERNS AND ATHEROGENICITY IN NON-INSULIN DEPENDENT DIABETES MELLITUS"
by: F. Kazerouni, et al.
Published: (2004-10-01)

"LDL SUBCLASS PATTERNS AND ATHEROGENICITY IN NON-INSULIN DEPENDENT DIABETES MELLITUS"
by: F. Kazerouni, et al.
Published: (2004-10-01)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
by: Estíbaliz Jarauta, et al.
Published: (2020-12-01)

Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
by: Tiwari Hemant K, et al.
Published: (2011-08-01)

Effect of Aqueous Extract of Walnut Leaves on Lipid Profile and Atherogenic Ratio in Hypercholesterolemic Rats
by: Rabia Azhar, Arif Siddiqui, Shazia Ali
Published: (2015-09-01)

Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase
by: Margaret E. Brousseau, et al.
Published: (1998-08-01)

ANKLE-BRACHIAL INDEX AND LDL-RECEPTOR GENE IN ASYMPTOMATIC SEVERE HYPERCHOLESTEROLEMIA
by: L. Vladimirova-Kitova
Published: (2011-08-01)

Lipoprotein metabolism in familial hypercholesterolemia
by: Kévin Chemello, et al.
Published: (2021-01-01)

Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies
by: Der-Yuan Chen, et al.
Published: (2021-05-01)

Accumulation of LDL/ox-LDL in the necrotic region participates in osteonecrosis of the femoral head: a pathological and in vitro study
by: Xin-Yuan Wang, et al.
Published: (2021-11-01)

Modified methylenedioxyphenol analogs lower LDL cholesterol through induction of LDL receptor expression
by: Zhekang Ying, et al.
Published: (2012-05-01)

Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate
by: Mohamad Dandan, et al.
Published: (2023-03-01)

Role of lipoprotein apheresis in the management of familial hypercholesterolemia
by: Shamanna Seshadri Iyengar, et al.
Published: (2021-01-01)

Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis
by: M.P. Adorni, et al.
Published: (2012-05-01)

Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice
by: Masa-aki Kawashiri, et al.
Published: (2001-06-01)

Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsia
by: G. León-Reyes, et al.
Published: (2018-05-01)

Metabolic origins and clinical significance of LDL heterogeneity
by: Kaspar K. Berneis, et al.
Published: (2002-09-01)

Severe Hypercholesterolemia Mediated by Lipoprotein X in an Immunosuppressed Patient: A Case Report
by: Cristiana Sequeira, et al.
Published: (2022-10-01)

Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population
by: Francisco J. Tinahones, et al.
Published: (2005-03-01)

Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: a 6 Months Prospective Study
by: Peter P. eToth, et al.
Published: (2016-01-01)